🇺🇸 CRL — Charles River Laboratories International, Inc.

Salud Compra
← Volver

Precio actual

313,02 USD

Máx. histórico

458,30

1868 días

Caída desde máximo

-31,70%

Rango 52 semanas

146,20 – 379,63

Variación hoy

-4,07%

Cierre anterior

326,29

Rango de hoy

311,73 – 330,75

Volumen hoy

1.661.321

Peor caída histórica

-78,23%

24/09/2021 → 11/04/2025

Aún sin recuperar

Volatilidad anualizada ⓘ

35,94%

Información
Nombre completo
Charles River Laboratories International, Inc.
Divisa
USD
Mercado
NYSE
Sector
Salud
Industria
Diagnostics & Research
Empleados
18.300
PER ⓘ
340,24 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
318,87 USD (puede no estar actualizado)
Primera cotización
23/06/2000
Precio actualizado
hace 19 horas
Sobre la empresa

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including genetically engineered models and services, insourcing solutions, and research animal diagnostic services; and engages in development and production of cell therapies. The Discovery and Safety Assessment segment offers in vitro and in vivo discovery services for the discovery, development, and safety testing of novel drugs, molecule compounds, oligonucleotides, and biotherapeutics, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services; and vivarium space services. The Manufacturing Solutions segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products; offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and contract development and manufacturing products and services. The company has collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization; and Medigen Vaccine Biologics Corp for developing next-generation multivalent enterovirus vaccine, enhance global regulatory readiness, and support IND-enabling non-clinical studies. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
31/01/2014 56,91 57,56 56,45 56,53 -1,79% 1,95% 480.400
30/01/2014 56,89 57,67 56,59 57,56 +2,02% 1,90% 602.000
29/01/2014 56,88 57,36 56,39 56,42 -0,72% 1,71% 642.600
28/01/2014 57,11 57,36 56,76 56,83 -0,33% 1,05% 464.800
27/01/2014 57,03 57,83 56,40 57,02 +0,05% 2,51% 803.200
24/01/2014 57,83 57,98 56,87 56,99 -1,69% 1,92% 414.500
23/01/2014 58,14 58,30 57,43 57,97 -0,53% 1,50% 521.000
22/01/2014 58,70 58,81 57,83 58,28 -0,72% 1,67% 516.300
21/01/2014 58,89 59,35 58,45 58,70 +0,00% 1,53% 258.700
17/01/2014 58,97 59,17 58,52 58,70 -0,83% 1,10% 352.000
16/01/2014 58,71 59,44 58,71 59,19 +0,70% 1,24% 279.200
15/01/2014 58,79 59,21 58,40 58,78 +0,36% 1,38% 374.600
14/01/2014 57,91 58,78 57,91 58,57 +1,00% 1,50% 477.300
13/01/2014 57,12 59,57 56,87 57,99 +1,99% 4,73% 1.438.400
10/01/2014 56,41 56,94 56,15 56,86 +0,74% 1,40% 583.000
09/01/2014 56,23 56,88 55,97 56,44 +0,75% 1,62% 386.000
08/01/2014 56,30 57,12 55,81 56,02 -0,50% 2,33% 896.000
07/01/2014 53,59 56,59 53,59 56,30 +6,27% 5,60% 1.690.200
06/01/2014 53,42 53,68 52,76 52,98 -0,90% 1,72% 709.200
03/01/2014 53,11 53,84 53,11 53,46 +1,10% 1,37% 390.400
02/01/2014 52,57 53,36 52,41 52,88 -0,30% 1,81% 580.500
31/12/2013 53,59 53,60 52,73 53,04 -0,60% 1,62% 408.900
30/12/2013 53,21 53,50 52,88 53,36 +0,06% 1,17% 197.700
27/12/2013 53,29 53,62 53,04 53,33 +0,15% 1,09% 176.100
26/12/2013 53,39 53,56 52,63 53,25 +0,11% 1,74% 181.100
24/12/2013 52,99 53,46 52,81 53,19 +0,45% 1,23% 159.100
23/12/2013 52,72 53,09 52,24 52,95 +0,38% 1,61% 437.700
20/12/2013 52,43 53,14 52,34 52,75 +0,88% 1,53% 810.200
19/12/2013 52,61 52,99 52,10 52,29 -0,93% 1,69% 423.400
18/12/2013 52,25 52,91 51,99 52,78 +1,17% 1,76% 438.700